Ikenaga Hiroki, Dai Kazuoki, Ishihara Masaharu
Department of Cardiology, Hiroshima City Hospital, 7-33, Moto-machi, Naka-ku, Hiroshima, 730-8518 Japan.
J Invasive Cardiol. 2010 Nov;22(11):557-8.
Sirolimus-eluting stents (SES) are now commonly used for percutaneous coronary intervention (PCI) because they dramatically reduce the rates of restenosis and target lesion revascularization, even in small vessels and long lesions as compared with bare-metal stent. The unresolved issue about SES use is the possibility of late stent thrombosis. Late stent thrombosis is a very rare, but serious complication that may result in acute myocardial infarction or sudden cardiac death. However, the mechanism of late stent thrombosis with SES has not been established. We report a patient with very late stent thrombosis 37 months after SES implantation who underwent optical coherence tomography and coronary angioscopy.
西罗莫司洗脱支架(SES)目前常用于经皮冠状动脉介入治疗(PCI),因为与裸金属支架相比,即使在小血管和长病变中,它也能显著降低再狭窄率和靶病变血管重建率。关于SES使用尚未解决的问题是晚期支架血栓形成的可能性。晚期支架血栓形成是一种非常罕见但严重的并发症,可能导致急性心肌梗死或心源性猝死。然而,SES导致晚期支架血栓形成的机制尚未明确。我们报告了1例在植入SES 37个月后发生极晚期支架血栓形成的患者,该患者接受了光学相干断层扫描和冠状动脉血管内镜检查。